Henrik Bengtsson,Toke Folke Christensen,Louise Wagner Petersen,Mads Schenstroem Stefansen
申请号：
US15464968
公开号：
US20170189616A1
申请日:
2017.03.21
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
